• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

质子泵抑制剂治疗引起的药物性皮疹伴嗜酸性粒细胞增多和全身症状及严重肾损伤:一例报告

Drug rash with eosinophilia and systemic symptoms and severe renal injury induced by proton pump inhibitor therapy: A case report.

作者信息

He Qien, Ying Guanghui, Fei Xiapei, Zha Chenqin, Chen Zhaogui, Bao Yishu, Long Jiaorong, Wang Zhujun, He Xuelin, Xia Min

机构信息

Department of Nephrology, Beilun People's Hospital, Ning Bo.

Kidney Disease Center, The First Affiliated Hospital, College of Medicine, Zhejiang University.

出版信息

Medicine (Baltimore). 2020 Oct 16;99(42):e22509. doi: 10.1097/MD.0000000000022509.

DOI:10.1097/MD.0000000000022509
PMID:33080685
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7572029/
Abstract

INTRODUCTION

Proton pump inhibitors (PPIs) are widely prescribed and generally well tolerated but can rarely cause severe allergic reactions, such as drug rash with eosinophilia and systemic symptoms (DRESS). We report a case of DRESS and renal injury induced by PPIs, and describe the therapeutic process.

PATIENT CONCERNS

The patient was a 66-year-old female who complained of fever, pruritus, desquamation, erythema multiforme, and anuria caused by omeprazole taken for 2 weeks to treat abdominal distention.

DIAGNOSIS

The clinical history revealed a similar episode of PPI-induced fever, eosinophilia, and acute kidney injury more than 1 year ago. The present laboratory tests revealed eosinophilia and oliguric renal failure. The renal biopsy was performed subsequently and proved the diagnosis of PPI-induced DRESS.

INTERVENTIONS

After the suspected diagnosis of PPI-induced DRESS, omeprazole was discontinued and methylprednisolone infusion (40 mg qd) was initiated. Because of oliguric renal failure, the patient received intermittent hemodialysis.

OUTCOMES

The patient initially responded to omeprazole discontinuation, hemodialysis, and glucocorticoids but later died from severe infection during the tapering of glucocorticoid therapy.

CONCLUSION

Clinicians should remain on high alert for potential life-threatening complications when prescribing PPIs. If unexplained renal injury develops in a patient taking a PPI, renal biopsy may help in identifying the pathogenesis and might facilitate timely intervention.

摘要

引言

质子泵抑制剂(PPIs)被广泛应用于临床,总体耐受性良好,但极少数情况下可引发严重过敏反应,如药物性皮疹伴嗜酸性粒细胞增多和全身症状(DRESS)。我们报告1例由PPIs引起的DRESS及肾损伤病例,并描述其治疗过程。

患者情况

该患者为66岁女性,因服用奥美拉唑2周治疗腹胀后出现发热、瘙痒、脱屑、多形红斑及无尿前来就诊。

诊断

临床病史显示,1年多前曾有过类似的由PPIs引起的发热、嗜酸性粒细胞增多及急性肾损伤发作。目前实验室检查显示嗜酸性粒细胞增多及少尿性肾衰竭。随后进行了肾活检,确诊为PPIs所致的DRESS。

干预措施

在疑似诊断为PPIs引起的DRESS后,停用奥美拉唑,并开始静脉输注甲泼尼龙(40mg,每日1次)。由于出现少尿性肾衰竭,患者接受了间歇性血液透析。

结果

患者最初对停用奥美拉唑、血液透析及糖皮质激素治疗有反应,但后来在糖皮质激素减量治疗期间死于严重感染。

结论

临床医生在开具PPIs处方时应高度警惕潜在的危及生命的并发症。如果服用PPIs的患者出现不明原因的肾损伤,肾活检可能有助于明确发病机制,并可能促进及时干预。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67b8/7572029/468f29970fa8/medi-99-e22509-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67b8/7572029/7d91865a50f3/medi-99-e22509-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67b8/7572029/fce16e4686e3/medi-99-e22509-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67b8/7572029/942acd989103/medi-99-e22509-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67b8/7572029/468f29970fa8/medi-99-e22509-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67b8/7572029/7d91865a50f3/medi-99-e22509-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67b8/7572029/fce16e4686e3/medi-99-e22509-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67b8/7572029/942acd989103/medi-99-e22509-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67b8/7572029/468f29970fa8/medi-99-e22509-g004.jpg

相似文献

1
Drug rash with eosinophilia and systemic symptoms and severe renal injury induced by proton pump inhibitor therapy: A case report.质子泵抑制剂治疗引起的药物性皮疹伴嗜酸性粒细胞增多和全身症状及严重肾损伤:一例报告
Medicine (Baltimore). 2020 Oct 16;99(42):e22509. doi: 10.1097/MD.0000000000022509.
2
Omeprazole-Associated Atypical Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) in a Patient with Positive In Vitro Diagnostic Testing to Multiple Proton Pump Inhibitors.一名对多种质子泵抑制剂体外诊断检测呈阳性的患者出现与奥美拉唑相关的伴嗜酸性粒细胞增多和全身症状的非典型药物反应(DRESS)
Chem Res Toxicol. 2024 Sep 16;37(9):1484-1487. doi: 10.1021/acs.chemrestox.4c00225. Epub 2024 Sep 4.
3
Omeprazole-induced drug reaction with eosinophilia and systemic symptoms (DRESS).奥美拉唑诱发的伴有嗜酸性粒细胞增多和全身症状的药物反应(DRESS)。
Eur J Dermatol. 2014 May-Jun;24(3):413-5. doi: 10.1684/ejd.2014.2343.
4
Omeprazole Induced Rapid Drug Reaction with Eosinophilia, Systemic Symptoms, and Cross-Reactivity in Delayed-Type Hypersensitivity Associated with Proton-Pump Inhibitors: A Case Report and Literature Review.奥美拉唑诱发的伴有嗜酸性粒细胞增多、全身症状的速发型药物反应以及与质子泵抑制剂相关的迟发型超敏反应中的交叉反应:一例报告及文献综述
Case Reports Immunol. 2024 Jan 3;2024:1317971. doi: 10.1155/2024/1317971. eCollection 2024.
5
Proton pump inhibitor-induced neutropenia: possible cross-reactivity between omeprazole and pantoprazole.质子泵抑制剂引起的中性粒细胞减少症:奥美拉唑和泮托拉唑之间可能存在交叉反应。
Clin Drug Investig. 2010;30(8):559-63. doi: 10.2165/11537230-000000000-00000.
6
Rowell's Syndrome Triggered by Omeprazole.奥美拉唑引发的罗威尔综合征。
Acta Dermatovenerol Croat. 2019 Jun;27(2):124-126.
7
Fatal clindamycin-induced drug rash with eosinophilia and systemic symptoms (DRESS) syndrome.致命性克林霉素诱导的药物疹伴嗜酸粒细胞增多和全身症状(DRESS)综合征。
Pharmacotherapy. 2012 Dec;32(12):e387-92. doi: 10.1002/phar.1142. Epub 2012 Nov 16.
8
Delayed-type hypersensitivity reactions induced by proton pump inhibitors: A clinical and in vitro T-cell reactivity study.质子泵抑制剂诱导的迟发型超敏反应:一项临床和体外 T 细胞反应性研究。
Allergy. 2018 Jan;73(1):221-229. doi: 10.1111/all.13235. Epub 2017 Jul 30.
9
DRESS syndrome: an important differential for eosinophilia with systemic organ dysfunction.药物反应伴嗜酸性粒细胞增多和全身器官功能障碍综合征:一种需要鉴别的重要疾病。
BMJ Case Rep. 2020 May 11;13(5):e234251. doi: 10.1136/bcr-2020-234251.
10
Immediate-type hypersensitivity reactions to proton pump inhibitors: usefulness of skin tests in the diagnosis and assessment of cross-reactivity.质子泵抑制剂致速发型超敏反应:皮肤试验在诊断和交叉反应评估中的作用。
Allergy. 2013 Aug;68(8):1008-14. doi: 10.1111/all.12189. Epub 2013 Jul 30.

引用本文的文献

1
Fatal outcome related to drug reaction with eosinophilia and systemic symptoms: a disproportionality analysis of FAERS database and a systematic review of cases.与嗜酸性粒细胞增多和全身症状的药物反应相关的致命结局:FAERS数据库的不成比例分析及病例系统评价
Front Immunol. 2024 Dec 16;15:1490334. doi: 10.3389/fimmu.2024.1490334. eCollection 2024.
2
Identification of novel signal of proton pump inhibitor-associated drug reaction with eosinophilia and systemic symptoms: a disproportionality analysis.质子泵抑制剂相关药物反应伴嗜酸性粒细胞增多和全身症状的新型信号识别:一项比例失调分析。
Int J Clin Pharm. 2024 Dec;46(6):1381-1390. doi: 10.1007/s11096-024-01778-y. Epub 2024 Jul 23.
3

本文引用的文献

1
The relationship between proton pump inhibitors and renal disease.质子泵抑制剂与肾脏疾病之间的关系。
J Bras Nefrol. 2018 Jul-Sep;40(3):301-306. doi: 10.1590/2175-8239-jbn-2018-0021. Epub 2018 Jul 10.
2
[Prescription of PPI in Germany: too often, too long, too much?].
MMW Fortschr Med. 2018 Feb;160(2):37-40. doi: 10.1007/s15006-018-0148-2.
3
Adverse Events of Proton Pump Inhibitors: Potential Mechanisms.质子泵抑制剂的不良事件:潜在机制
Curr Drug Metab. 2018;19(2):142-154. doi: 10.2174/1389200219666171207125351.
Omeprazole Induced Rapid Drug Reaction with Eosinophilia, Systemic Symptoms, and Cross-Reactivity in Delayed-Type Hypersensitivity Associated with Proton-Pump Inhibitors: A Case Report and Literature Review.
奥美拉唑诱发的伴有嗜酸性粒细胞增多、全身症状的速发型药物反应以及与质子泵抑制剂相关的迟发型超敏反应中的交叉反应:一例报告及文献综述
Case Reports Immunol. 2024 Jan 3;2024:1317971. doi: 10.1155/2024/1317971. eCollection 2024.
4
Investigating Skin Rashes Associated With Pantoprazole Medication: Causes and Clinical Implications.泮托拉唑药物相关皮肤皮疹的调查:病因及临床意义
Cureus. 2023 Sep 3;15(9):e44623. doi: 10.7759/cureus.44623. eCollection 2023 Sep.
5
A Rare Case of Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome Leading to Hemodialysis and Multiple Infections: A Case Report and Literature Review.药物超敏反应伴嗜酸性粒细胞增多和全身症状综合征导致血液透析及多种感染的罕见病例:病例报告及文献综述
Intern Med. 2024 Apr 15;63(8):1131-1138. doi: 10.2169/internalmedicine.1959-23. Epub 2023 Aug 23.
6
Renal Manifestations of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome: A Systematic Review of 71 Cases.药物超敏反应伴嗜酸性粒细胞增多和全身症状(DRESS)综合征的肾脏表现:71例病例的系统评价
J Clin Med. 2023 Jul 10;12(14):4576. doi: 10.3390/jcm12144576.
7
An Efficient Stacked Deep Transfer Learning Model for Automated Diagnosis of Lyme Disease.一种用于莱姆病自动诊断的高效堆叠深度迁移学习模型。
Comput Intell Neurosci. 2022 Feb 28;2022:2933015. doi: 10.1155/2022/2933015. eCollection 2022.
4
Proton Pump Inhibitors and Kidney Disease - GI Upset for the Nephrologist?质子泵抑制剂与肾脏疾病——肾脏病医生面临的胃肠道不适问题?
Kidney Int Rep. 2017 May;2(3):297-301. doi: 10.1016/j.ekir.2017.01.005. Epub 2017 Jan 23.
5
Delayed-type hypersensitivity reactions induced by proton pump inhibitors: A clinical and in vitro T-cell reactivity study.质子泵抑制剂诱导的迟发型超敏反应:一项临床和体外 T 细胞反应性研究。
Allergy. 2018 Jan;73(1):221-229. doi: 10.1111/all.13235. Epub 2017 Jul 30.
6
Association Between Proton Pump Inhibitor Use and Risk of Progression of Chronic Kidney Disease.质子泵抑制剂的使用与慢性肾脏病进展风险的关联。
Gastroenterology. 2017 Sep;153(3):702-710. doi: 10.1053/j.gastro.2017.05.046. Epub 2017 Jun 2.
7
Long-term outcome in biopsy-proven acute interstitial nephritis treated with steroids.经活检证实的急性间质性肾炎接受类固醇治疗的长期预后。
Clin Kidney J. 2017 Apr;10(2):233-239. doi: 10.1093/ckj/sfw116. Epub 2016 Dec 24.
8
Medication-Induced Interstitial Nephritis in the 21st Century.21世纪的药物性间质性肾炎
Adv Chronic Kidney Dis. 2017 Mar;24(2):72-79. doi: 10.1053/j.ackd.2016.11.016.
9
Management of Hypersensitivity Reactions to Proton Pump Inhibitors: A Retrospective Experience.质子泵抑制剂超敏反应的管理:一项回顾性研究经验
Int Arch Allergy Immunol. 2016;171(1):54-60. doi: 10.1159/000450952. Epub 2016 Nov 12.
10
Proton pump inhibitors are associated with increased risk of development of chronic kidney disease.质子泵抑制剂与慢性肾脏病发生风险增加相关。
BMC Nephrol. 2016 Aug 3;17(1):112. doi: 10.1186/s12882-016-0325-4.